ChemImage to Present Results From a Study Utilizing Hyperspectral Imaging to Discriminate Black Pen Inks at AAFS

This version of Wbna40925631 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.

PITTSBURGH, Jan. 5, 2011 (GLOBE NEWSWIRE) -- Results from a blinded hyperspectral imaging (HSI) study examining ink from 44 black ballpoint pens, totaling 500 ink samples in all, will be presented, Friday, Feb. 25 from 11:30-11:50 a.m. at the American Academy of Forensic Sciences (AAFS) 63rd Annual Scientific Meeting at the Hyatt Regency Hotel in Chicago.

PITTSBURGH, Jan. 5, 2011 (GLOBE NEWSWIRE) -- Results from a blinded hyperspectral imaging (HSI) study examining ink from 44 black ballpoint pens, totaling 500 ink samples in all, will be presented, Friday, Feb. 25 from 11:30-11:50 a.m. at the American Academy of Forensic Sciences (AAFS) 63rd Annual Scientific Meeting at the Hyatt Regency Hotel in Chicago.

Conducted by ChemImage Corporation, the study will look at different combinations of pen pair samples to better ascertain HSI's ability to detect, discriminate and provide sample-to-sample and sample-to-background contrast. In addition to discussing overall results, the presentation will address any potential sources of error, as well as provide a general comparison of HSI performance to other ink discrimination techniques.

The pen pairs utilized in the ChemImage study originated from research results published in the July 2007 edition of the Journal of Forensic Sciences, where video spectral analysis and lab color mode were used to analyze 990 black ballpoint pen pair ink samples.

In addition to the presentation, ChemImage will be exhibiting at booth #912 at the conference, where it will be giving away an iPad.

For more information on the company's forensic applications, visit: .

Media Contact:
Suzanne Cibotti
Sr. Marketing Communications Specialist
(412) 241-7335, ext. 291
cibottis@chemimage.com

About ChemImage

ChemImage Corporation, a leader in hyperspectral imaging technology (i.e., molecular chemical imaging), provides instrumentation, software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art Hyperspectral Imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage's headquarters are located in Pittsburgh, Pa., where it houses research and development laboratories, as well as engineering and manufacturing facilities.

This information was brought to you by Cision

×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone